Report cover image

Genomics Market

Publisher Fortune Business Insights Pvt. Ltd.
Published Sep 01, 2024
Length 160 Pages
SKU # FOB19185523

Description

Genomics Market



Growth Factors of Genomics Market

The Genomics Market size was valued at USD 27.75 billion in 2023. The market is projected to be worth USD 30.75 billion in 2024 and reach USD 80.17 billion by 2032, exhibiting a CAGR of 12.7% during the forecast period of 2024-2032.

The COVID-19 pandemic considerably impacted the genomics market, driving rapid enhancements and adoption of genomic technologies. The name for for genomics surged as governments and healthcare establishments depended on genetic sequencing to tune virus mutations and expand vaccines. Companies supplying genomic attempting out and analytics noticed sizable increase, at the same time as investment in genomics studies elevated globally. The pandemic highlighted the importance of genomic generation in expertise pathogens and making equipped for destiny health crises, main to extended improvements and collaborations throughout the biotech quarter. This has in the end improved the position of genomics in healthcare, diagnostics, and custom designed medicine.

One key fashion in the genomics marketplace is the upward thrust of direct-to-customer (DTC) genetic checking out. Consumers are more and more interested in information their genetic make-up for insights into health, ancestry, and predispositions to nice ailments. DTC groups like 23andMe and AncestryDNA have acquired popularity because of the convenience of at-home trying out kits, paired with advanced genetic evaluation equipment. As a quit result, genomics has come to be extra available to the general public, fostering a broader understanding of genetics and private health, even as simultaneously using innovation in customized treatment.

A predominant using factor in the again of the increase of the genomics marketplace is the falling cost of DNA sequencing. Technological improvements have notably reduced the charge of sequencing a human genome from millions of dollars to only a few hundred. This affordability has opened the door for great genomic studies, permitting researchers and healthcare vendors to mix genomic facts into medical practices. Lower charges have additionally endorsed biopharma organizations to apply genomics in drug improvement, helping in the discovery of extra targeted and effective treatments. The accessibility of inexpensive sequencing is propelling the genomics marketplace ahead.

Comprehensive Analysis of Genomics Market

The Genomics Market growth is rising at an exponential rate due to its marketplace segmentation. This market expansion correctly affords a detailed local assessments thinking about the dominant supply and call for forces that effect the enterprise. These segmentations are methodically segregated by type, by application, by technology, by end user. By Type include Products , Services. By Technology include Polymerase Chain Reaction (PCR), Next-generation Sequencing (NGS), Microarray, Sanger Sequencing, Others. By Application include Diagnostics, Research, Others. By End User include Research Institutes ,Healthcare Facilities & Diagnostic Centers, Pharmaceutical & Biotechnological Companies, Contract Research Organization (CROs).

The North America region lead the Genomics Market share by benefitting a market size of USD 12.13 billion The rapid adoption of new sequencing technologies and shift towards personalized medicines are expected to render a leading position to North America .

The top players in the market play a crucial role in the industry assuring market growth and setting market standards. These players include, Google LLC (Alphabet, Inc.), Magic Leap, Inc., ReWalk Robotics, SAMSUNG, B-Temia, Panasonic Holdings Corporation, NVIDIA Corporation, Microsoft, Ekso Bionics, Vuzix,these market players provide a level-playing competitive landscape.

January 2024 – Gencove and Ferris Genomics announced the collaboration for end-to-stop genomics sequencing services.

Segmentation Table

ATTRIBUTE DETAILS

Study Period 2019-2032

Base Year 2023

Estimated Year 2024

Forecast Period 2024-2032

Historical Period 2019-2022

Growth Rate CAGR of 12.7% from 2024-2032

Unit Value (USD billion)

Segmentation By Type

- Products
  • Instruments & Software
  • Consumables
- Services

By Technology

- Polymerase Chain Reaction (PCR)

- Next-generation Sequencing (NGS)

- Microarray

- Sanger Sequencing

- Others

By Application

- Diagnostics

- Research

- Others

By End User

- Research Institutes

- Healthcare Facilities & Diagnostic Centers

- Pharmaceutical & Biotechnological Companies

- Contract Research Organization (CROs)

By Region

- North America (By Type, Technology, Application, End User, and Country)
  • U.S.
  • Canada
- Europe (By Type, Technology, Application, End User, and Country/Sub-region)
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
- Asia Pacific (By Type, Technology, Application, End User, and Country/Sub-region)
  • Japan
  • China
  • India
  • Australia
  • Southeast Asia
  • Rest of Asia Pacific
- Latin America (By Type, Technology, Application, End User, and Country/Sub-region)
  • Brazil
  • Mexico
  • Rest of Latin America
- Middle East & Africa (By Type, Technology, Application, End User, and Country/Sub-region)
  • GCC
  • South Africa
  • Rest of Middle East & Africa


    • Please Note: It will take 5-6 business days to complete the report upon order confirmation.

Table of Contents

160 Pages
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Market Trends
4. Key Insights
4.1. Overview of Genomic Projects – For Key Countries
4.2. Overview of Genomic Services
4.3. New Product Launches, By Key Players
4.4. Key Industry Developments - Mergers, Acquisitions and Partnerships
4.5. Impact of COVID-19 on the Market
5. Global Genomics Market Analysis, Insights and Forecast, 2019-2032
5.1. Market Analysis, Insights and Forecast – By Type
5.1.1. Products
5.1.1.1. Instruments & Software
5.1.1.2. Consumables
5.1.2. Services
5.2. Market Analysis, Insights and Forecast – By Technology
5.2.1. Polymerase Chain Reaction (PCR)
5.2.2. Next-generation Sequencing (NGS)
5.2.3. Microarray
5.2.4. Sanger Sequencing
5.2.5. Others
5.3. Market Analysis, Insights and Forecast – By Application
5.3.1. Diagnostics
5.3.2. Research
5.3.3. Others
5.4. Market Analysis, Insights and Forecast – By End User
5.4.1. Research Institutes
5.4.2. Healthcare Facilities & Diagnostic Centers
5.4.3. Pharmaceutical & Biotechnological Companies
5.4.4. Contact Research Organizations (CROs)
5.5. Market Analysis, Insights and Forecast – By Region
5.5.1. North America
5.5.2. Europe
5.5.3. Asia Pacific
5.5.4. Latin America
5.5.5. Middle East & Africa
6. North America Genomics Market Analysis, Insights and Forecast, 2019-2032
6.1. Market Analysis, Insights and Forecast – By Type
6.1.1. Products
6.1.1.1. Instruments & Software
6.1.1.2. Consumables
6.1.2. Services
6.2. Market Analysis, Insights and Forecast – By Technology
6.2.1. Polymerase Chain Reaction (PCR)
6.2.2. Next-generation Sequencing (NGS)
6.2.3. Microarray
6.2.4. Sanger Sequencing
6.2.5. Others
6.3. Market Analysis, Insights and Forecast – By Application
6.3.1. Diagnostics
6.3.2. Research
6.3.3. Others
6.4. Market Analysis, Insights and Forecast – By End User
6.4.1. Research Institutes
6.4.2. Healthcare Facilities & Diagnostic Centers
6.4.3. Pharmaceutical & Biotechnological Companies
6.4.4. Contact Research Organizations (CROs)
6.5. Market Analysis, Insights and Forecast – By Country
6.5.1. U.S.
6.5.2. Canada
7. Europe Genomics Market Analysis, Insights and Forecast, 2019-2032
7.1. Market Analysis, Insights and Forecast – By Type
7.1.1. Products
7.1.1.1. Instruments & Software
7.1.1.2. Consumables
7.1.2. Services
7.2. Market Analysis, Insights and Forecast – By Technology
7.2.1. Polymerase Chain Reaction (PCR)
7.2.2. Next-generation Sequencing (NGS)
7.2.3. Microarray
7.2.4. Sanger Sequencing
7.2.5. Others
7.3. Market Analysis, Insights and Forecast – By Application
7.3.1. Diagnostics
7.3.2. Research
7.3.3. Others
7.4. Market Analysis, Insights and Forecast – By End User
7.4.1. Research Institutes
7.4.2. Healthcare Facilities & Diagnostic Centers
7.4.3. Pharmaceutical & Biotechnological Companies
7.4.4. Contact Research Organizations (CROs)
7.5. Market Analysis, Insights and Forecast – By Country/ Sub-region
7.5.1. U.K.
7.5.2. Germany
7.5.3. France
7.5.4. Spain
7.5.5. Italy
7.5.6. Rest of Europe
8. Asia Pacific Genomics Market Analysis, Insights and Forecast, 2019-2032
8.1. Market Analysis, Insights and Forecast – By Type
8.1.1. Products
8.1.1.1. Instruments & Software
8.1.1.2. Consumables
8.1.2. Services
8.2. Market Analysis, Insights and Forecast – By Technology
8.2.1. Polymerase Chain Reaction (PCR)
8.2.2. Next-generation Sequencing (NGS)
8.2.3. Microarray
8.2.4. Sanger Sequencing
8.2.5. Others
8.3. Market Analysis, Insights and Forecast – By Application
8.3.1. Diagnostics
8.3.2. Research
8.3.3. Others
8.4. Market Analysis, Insights and Forecast – By End User
8.4.1. Research Institutes
8.4.2. Healthcare Facilities & Diagnostic Centers
8.4.3. Pharmaceutical & Biotechnological Companies
8.4.4. Contact Research Organizations (CROs)
8.5. Market Analysis, Insights and Forecast – By Country/ Sub-region
8.5.1. Japan
8.5.2. China
8.5.3. India
8.5.4. Australia
8.5.5. Southeast Asia
8.5.6. Rest of Asia Pacific
9. Latin America Genomics Market Analysis, Insights and Forecast, 2019-2032
9.1. Market Analysis, Insights and Forecast – By Type
9.1.1. Products
9.1.1.1. Instruments & Software
9.1.1.2. Consumables
9.1.2. Services
9.2. Market Analysis, Insights and Forecast – By Technology
9.2.1. Polymerase Chain Reaction (PCR)
9.2.2. Next-generation Sequencing (NGS)
9.2.3. Microarray
9.2.4. Sanger Sequencing
9.2.5. Others
9.3. Market Analysis, Insights and Forecast – By Application
9.3.1. Diagnostics
9.3.2. Research
9.3.3. Others
9.4. Market Analysis, Insights and Forecast – By End User
9.4.1. Research Institutes
9.4.2. Healthcare Facilities & Diagnostic Centers
9.4.3. Pharmaceutical & Biotechnological Companies
9.4.4. Contact Research Organizations (CROs)
9.5. Market Analysis, Insights and Forecast – By Country/ Sub-regions
9.5.1. Brazil
9.5.2. Mexico
9.5.3. Rest of Latin America
10. Middle East & Africa Genomics Market Analysis, Insights and Forecast, 2019-2032
10.1. Market Analysis, Insights and Forecast – By Type
10.1.1. Products
10.1.1.1. Instruments & Software
10.1.1.2. Consumables
10.1.2. Services
10.2. Market Analysis, Insights and Forecast – By Technology
10.2.1. Polymerase Chain Reaction (PCR)
10.2.2. Next-generation Sequencing (NGS)
10.2.3. Microarray
10.2.4. Sanger Sequencing
10.2.5. Others
10.3. Market Analysis, Insights and Forecast – By Application
10.3.1. Diagnostics
10.3.2. Research
10.3.3. Others
10.4. Market Analysis, Insights and Forecast – By End User
10.4.1. Research Institutes
10.4.2. Healthcare Facilities & Diagnostic Centers
10.4.3. Pharmaceutical & Biotechnological Companies
10.4.4. Contact Research Organizations (CROs)
10.5. Market Analysis, Insights and Forecast – By Country/ Sub-region
10.5.1. South Africa
10.5.2. GCC
10.5.3. Rest of Middle East & Africa
11. Competitive Analysis
11.1. Global Market Share Analysis (2023)
11.2. Company Profiles
11.2.1. Illumina Inc.
11.2.1.1. Overview
11.2.1.2. Products & Services
11.2.1.3. SWOT Analysis
11.2.1.4. Recent Developments
11.2.1.5. Strategies
11.2.1.6. Financials (Based on Availability)
11.2.2. Thermo Fisher Scientific Inc.
11.2.2.1. Overview
11.2.2.2. Products & Services
11.2.2.3. SWOT Analysis
11.2.2.4. Recent Developments
11.2.2.5. Strategies
11.2.2.6. Financials (Based on Availability)
11.2.3. Agilent Technologies, Inc.
11.2.3.1. Overview
11.2.3.2. Products & Services
11.2.3.3. SWOT Analysis
11.2.3.4. Recent Developments
11.2.3.5. Strategies
11.2.3.6. Financials (Based on Availability)
11.2.4. F.Hoffmann-La Roche Ltd.
11.2.4.1. Overview
11.2.4.2. Products & Services
11.2.4.3. SWOT Analysis
11.2.4.4. Recent Developments
11.2.4.5. Strategies
11.2.4.6. Financials (Based on Availability)
11.2.5. Oxford Nanopore Technologies
11.2.5.1. Overview
11.2.5.2. Products & Services
11.2.5.3. SWOT Analysis
11.2.5.4. Recent Developments
11.2.5.5. Strategies
11.2.5.6. Financials (Based on Availability)
11.2.6. Danaher
11.2.6.1. Overview
11.2.6.2. Products & Services
11.2.6.3. SWOT Analysis
11.2.6.4. Recent Developments
11.2.6.5. Strategies
11.2.6.6. Financials (Based on Availability)
11.2.7. BGI
11.2.7.1. Overview
11.2.7.2. Products & Services
11.2.7.3. SWOT Analysis
11.2.7.4. Recent Developments
11.2.7.5. Strategies
11.2.7.6. Financials (Based on Availability)
11.2.8. IntegraGen
11.2.8.1. Overview
11.2.8.2. Products & Services
11.2.8.3. SWOT Analysis
11.2.8.4. Recent Developments
11.2.8.5. Strategies
11.2.8.6. Financials (Based on Availability)
11.2.9. General Electric Company
11.2.9.1. Overview
11.2.9.2. Products & Services
11.2.9.3. SWOT Analysis
11.2.9.4. Recent Developments
11.2.9.5. Strategies
11.2.9.6. Financials (Based on Availability)

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us